FindTrial
Sign In

Effect of ropivacaine on uterine and abdominal muscle pushing power during the first and second stage of labor

Effect of ropivacaine on uterine and abdominal muscle pushing power during the first and second stage of labor

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017444
Enrollment
Unknown
Registered
2018-07-30
Start date
2015-01-01
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

labor analgesia

Interventions

one:0.0625% ropivacaine for patient-controlled epidural analgesia (PCEA)
two:0.0625% levobupivacaine for PCEA
three: no PCEA

Sponsors

Guangzhou Women and Children Medical Center
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Parturient women

Exclusion criteria

Exclusion criteria: Caesarean section

Design outcomes

Primary

MeasureTime frame
VAS;various electromyographic parameters;—

Countries

China

Contacts

Public ContactBaisongZhao

Guangzhou Women and Children Medical Center

zhaobaisong819@163.com+86 13642665097

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026